LEADER 02973oam  2200685I  450 
001 9910461903803321
005 20200520144314.0
010   $a1-283-64267-0
010   $a0-203-11657-7
010   $a1-136-29968-8
024 7 $a10.4324/9780203116579 
035   $a(CKB)2670000000259449
035   $a(EBL)1039376
035   $a(OCoLC)812786701
035   $a(SSID)ssj0000758356
035   $a(PQKBManifestationID)12319347
035   $a(PQKBTitleCode)TC0000758356
035   $a(PQKBWorkID)10780746
035   $a(PQKB)10081906
035   $a(MiAaPQ)EBC1039376
035   $a(Au-PeEL)EBL1039376
035   $a(CaPaEBR)ebr10611744
035   $a(CaONFJC)MIL395517
035   $a(EXLCZ)992670000000259449
100   $a20180706d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aOrganizations and the bioeconomy $ethe management and commodification of the life sciences /$fAlexander Styhre
205   $a1st ed.
210  1$aNew York :$cRoutledge,$d2012.
215   $a1 online resource (203 p.)
225 1 $aRoutledge studies in management, organizations, and society ;$v18
300   $aDescription based upon print version of record.
311   $a1-138-10734-4 
311   $a0-415-52926-3 
320   $aIncludes bibliographical references and index.
327   $aThe concept of the bioeconomy -- Biopolitics, neoliberalism, and the calculative worldview : the economics of life -- New drug development, biotechnology and the enactment of life -- The tissue economy -- Living in and managing the bioeconomy.
330   $aThe advancement of the life sciences and the technosciences has enhanced the longevity of citizens in the Western world, and half of the generation born in the first decade of the new millennium is now expected to live to the age of one hundred years. In a society with such longevity and affluence, consumption of health-related goods and services such as pharmaceuticals and scanning procedures may be seen as a sustainable source of income for the industries that promote it. Though the healthcare sector has traditionally been organized in the public sector in Europe and in the private sector
410  0$aManagement, organizations and society (London, England) ;$vv. 18.
606   $aBiotechnology$xEconomic aspects
606   $aLife sciences$xEconomic aspects
606   $aBiotechnology industries
606   $aMedical economics
608   $aElectronic books.
615  0$aBiotechnology$xEconomic aspects.
615  0$aLife sciences$xEconomic aspects.
615  0$aBiotechnology industries.
615  0$aMedical economics.
676   $a338.4/76606
700   $aStyhre$b Alexander.$0616190
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910461903803321
996   $aOrganizations and the bioeconomy$92043620
997   $aUNINA